Dermatoloxía
Servizo
Almudena
Mateu Puchades
Publicacións nas que colabora con Almudena Mateu Puchades (8)
2024
-
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
British Journal of Dermatology, Vol. 190, Núm. 3, pp. 355-363
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
2022
-
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study
Dermatologic Therapy
-
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 4, pp. 401-406
2021
-
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Journal of the American Academy of Dermatology, Vol. 84, Núm. 2, pp. 513-517
-
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology